CLEMASTINE Drug Patent Profile

Which patents cover Clemastine, and when can generic versions of Clemastine launch?

Clemastine is a drug marketed by Actavis Mid Atlantic, Apotex Inc, Genus, New Heightsrx, Teva Pharms, Wockhardt Bio Ag, Ani Pharms, L Perrigo Co, Omnivium Pharms, and Pld Acquisitions Llc. and is included in eleven NDAs.

The generic ingredient in CLEMASTINE is clemastine fumarate. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the clemastine fumarate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Clemastine

A generic version of CLEMASTINE was approved as clemastine fumarate by GENUS on January 31^st, 1992.

Summary for CLEMASTINE

US Patents:	0
Applicants:	10
NDAs:	11
Drug Prices:	Drug price information for CLEMASTINE
DailyMed Link:	CLEMASTINE at DailyMed

See drug prices for CLEMASTINE

See drug sales revenues for CLEMASTINE

US Patents and Regulatory Information for CLEMASTINE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Actavis Mid Atlantic	CLEMASTINE FUMARATE	clemastine fumarate	SYRUP;ORAL	074075-001	Oct 31, 1993		DISCN	No	No
Ani Pharms	CLEMASTINE FUMARATE	clemastine fumarate	TABLET;ORAL	073282-001	Jan 31, 1992		DISCN	No	No
New Heightsrx	CLEMASTINE FUMARATE	clemastine fumarate	SYRUP;ORAL	074884-001	Dec 17, 1997	AA	RX	No	No
Pld Acquisitions Llc	CLEMASTINE FUMARATE	clemastine fumarate	TABLET;ORAL	073458-001	Oct 31, 1993		DISCN	No	No
Ani Pharms	CLEMASTINE FUMARATE	clemastine fumarate	TABLET;ORAL	073282-002	Dec 3, 1992		DISCN	No	No
Apotex Inc	CLEMASTINE FUMARATE	clemastine fumarate	SYRUP;ORAL	075703-001	Nov 27, 2000		DISCN	No	No
Genus	CLEMASTINE FUMARATE	clemastine fumarate	SYRUP;ORAL	073399-001	Jun 30, 1994	AA	RX	No	Yes

DrugChatter Q&A for CLEMASTINE

Clemastine fumarate class ethanolamine antihistamine structure?